Article
Circulating Mitochondrial Nucleic Acids Have Prognostic Value for Survival in Patients with Advanced Prostate Cancer
15 Jan 2007
Abstract excerpt
PURPOSE: Advanced prostate cancer represents a heterogeneous disease entity with differences in clinical behavior, response to therapy, and survival. We assessed whether we could distinguish poor from good prognosis patients at presentation in our clinic by means of quantifying circulating cell-free mitochondrial and genomic nucleic acids in plasma. EXPERIMENTAL DESIGN: We collected plasma from 75 prostate cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
